The Latest Analyst Ratings For Immunocore Hldgs
Portfolio Pulse from Benzinga Insights
In the last three months, 7 analysts have rated Immunocore Holdings (NASDAQ:IMCR), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target is $83.29, down 4.58% from the previous $87.29. Analysts have adjusted their ratings and price targets, reflecting their views on the company's market position and financial performance.
August 28, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Immunocore Holdings has received mixed analyst ratings, with a current average price target of $83.29, which is 4.58% lower than the previous average. Analysts have adjusted their ratings and price targets, indicating varied expectations for the company's future performance.
The article discusses recent analyst ratings for Immunocore Holdings, showing a mix of bullish and somewhat bullish sentiments. The average price target has decreased, indicating a slight negative shift in expectations. However, the presence of bullish ratings suggests some positive outlooks. The impact on the stock price is likely neutral in the short term as the mixed ratings balance each other out.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100